Investment Day: Neko Health Raises $700M to Make Preventive Healthcare the Norm

Daniel Ek built Spotify to put music in every pocket. Now he’s building Neko Health to put a doctor-grade health scan in every city. On July 15, 2026, the Stockholm-based company closed a $700 million Series C — one of the largest raises in European health tech history — led by Lightspeed Venture Partners and co-led by O.G. Their US expansion starts now.

What Neko Health actually does

Neko’s core product is the Neko Health Scan — a 60-minute, comprehensive, non-invasive, radiation-free health assessment that captures millions of data points. Priced at £299 in the UK and 2,750 SEK in Sweden, there’s no GP referral required and no waiting list. You book a slot, walk in, and leave with a full picture of your body. The company owns its entire tech stack in-house — hardware, software, and clinical protocol — which lets it iterate faster than any competitor in the space.

The deal at a glance

💰 Round: $700M Series C

🏦 Lead investor: Lightspeed Venture Partners

🌍 Headquarters: Stockholm, Sweden

🚀 Founded by Daniel Ek (Spotify co-founder) and Hjalmar Nilsonne

📍 Next milestone: US market launch

💼 Total raised to date: over $960M+ (following a $260M Series B in January 2025)

3 questions with Bejul Somaia, Global Partner at Lightspeed Venture Partners

Q: Why Neko Health, and why now?

‘We’ve known Hjalmar, Daniel and the founding team at Neko Health for years and have deep respect for their vision to redefine health for more than just the privileged few, on a global scale. They execute at a level few can match.’ The macro tailwind here is undeniable: the global healthcare system is shifting from reactive treatment to proactive prevention, and the addressable market for early-detection diagnostics is enormous. Lightspeed sees Neko as the company best positioned to own that transition at scale.

Q: What makes this different from other health diagnostics players?

Most diagnostics companies rely on third-party hardware, outsourced software, or fragmented clinical protocols. Neko owns the full stack — hardware, software, and clinical protocol — which means tighter quality control, faster iteration, and a better patient experience. The non-invasive, radiation-free approach at a genuinely accessible price point is the other differentiator: this is preventive health that was previously available only to the ultra-wealthy, now democratised for everyone.

Q: What does success look like in five years?

In five years, Neko Health is the standard for preventive health scanning across major US and European cities. Millions of members have longitudinal health data — not just a one-time snapshot — and that data asset is beginning to reshape how medicine is practised. The goal isn’t just to build a great product; it’s to build the infrastructure that makes proactive health the default, not the exception.

Why this matters for founders

Preventive health is no longer niche. Investors are backing companies that intercept disease early, reduce system burden, and build direct-to-consumer trust at scale. Founders building in health diagnostics, wellness tech, and consumer health should take note — the capital is moving here, and it’s moving fast.

This raise signals something bigger: the era of reactive healthcare is ending. The companies building the infrastructure for proactive health — the ones that own their stack, price for accessibility, and think in decades — are attracting the largest cheques in the market. If you’re building in this space, the window is open.

Follow @NekoHealth and @Lightspeed for updates as the US rollout unfolds. And if you’re a founder building in preventive health — this is your green light.